Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $217M (100.0% shares, 0.0% debt)

Holdings (15)

— KITE PHARMA INC 48.6%

Value $106M Shares 2,358,084 Share Price $44.84 Est. Cost/Share $57.67 Unrealized @ Report Date —

CSGP COSTAR GROUP INC 16.9%

Value $36.78M Shares 195,117 Share Price $188.49 * Est. Cost/Share $16.16 Unrealized @ Report Date +16.7%

— NANTKWEST INC 11.8%

Value $25.66M Shares 4,485,495 Share Price $5.72 Est. Cost/Share $11.46 Unrealized @ Report Date —

SRNE SORRENTO THERAPEUTICS INC 6.3%

Value $13.72M Shares 2,799,790 Share Price $4.90 Est. Cost/Share $12.08 Unrealized @ Report Date -59.4%

MDXG MIMEDX GROUP INC 4.4%

Value $9.572M Shares 1,080,365 Share Price $8.86 Est. Cost/Share $8.80 Unrealized @ Report Date +0.7%

— BARCLAYS BK PLC 3.8%

Value $8.179M Shares 320,600 Share Price $25.51 Est. Cost/Share $25.51 Unrealized @ Report Date —

LPLA LPL FINL HLDGS INC 3.3%

Value $7.276M Shares 206,647 Share Price $35.21 Est. Cost/Share $43.12 Unrealized @ Report Date -18.3%

— COMMUNICATIONS SALES&LEAS IN 1.9%

Value $4.142M Shares 163,000 Share Price $25.41 Est. Cost/Share $25.41 Unrealized @ Report Date —

— ISHARES TR 1.3%

Value $2.76M Shares 10,400 Share Price $265.38 Est. Cost/Share $265.38 Unrealized @ Report Date —

— NANTHEALTH INC 1.1%

Value $2.374M Shares 238,828 Share Price $9.94 Est. Cost/Share $12.47 Unrealized @ Report Date —

EDIT EDITAS MEDICINE INC 0.3%

Value $671K Shares 41,324 Share Price $16.24 Est. Cost/Share $26.29 Unrealized @ Report Date -38.3%

IBB ISHARES TR 0.2%

Value $456K Shares 1,719 Share Price $265.27 * Est. Cost/Share $95.13 Unrealized @ Report Date -7.0%

NTLA INTELLIA THERAPEUTICS INC 0.0%

Value $46,000 Shares 3,542 Share Price $12.99 Est. Cost/Share $15.02 Unrealized @ Report Date -12.7%

— ADVERUM BIOTECHNOLOGIES INC 0.0%

Value $44,000 Shares 15,000 Share Price $2.93 Est. Cost/Share $2.93 Unrealized @ Report Date —

GM GENERAL MTRS CO 0.0%

Value $28,000 Shares 800 Share Price $35.00 * Est. Cost/Share $28.16 Unrealized @ Report Date +4.4%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	KITE PHARMA INC	2,358,084	$106M	48.6%	$44.84	$57.67	—	COM	49803L109
CSGP	COSTAR GROUP INC	195,117	$36.78M	16.9%	$188.49 *	$16.16	+16.7%	COM	22160N109
—	NANTKWEST INC	4,485,495	$25.66M	11.8%	$5.72	$11.46	—	COM	63016Q102
SRNE	SORRENTO THERAPEUTICS INC	2,799,790	$13.72M	6.3%	$4.90	$12.08	-59.4%	COM NEW	83587F202
MDXG	MIMEDX GROUP INC	1,080,365	$9.572M	4.4%	$8.86	$8.80	+0.7%	COM	602496101
—	BARCLAYS BK PLC	320,600	$8.179M	3.8%	$25.51	$25.51	—	CALL	06740Q902
LPLA	LPL FINL HLDGS INC	206,647	$7.276M	3.3%	$35.21	$43.12	-18.3%	COM	50212V100
—	COMMUNICATIONS SALES&LEAS IN	163,000	$4.142M	1.9%	$25.41	$25.41	—	COM	20341J104
—	ISHARES TR	10,400	$2.76M	1.3%	$265.38	$265.38	—	CALL	464287906
—	NANTHEALTH INC	238,828	$2.374M	1.1%	$9.94	$12.47	—	COM	630104107
EDIT	EDITAS MEDICINE INC	41,324	$671K	0.3%	$16.24	$26.29	-38.3%	COM	28106W103
IBB	ISHARES TR	1,719	$456K	0.2%	$265.27 *	$95.13	-7.0%	NASDQ BIOTEC ETF	464287556
NTLA	INTELLIA THERAPEUTICS INC	3,542	$46,000	0.0%	$12.99	$15.02	-12.7%	COM	45826J105
—	ADVERUM BIOTECHNOLOGIES INC	15,000	$44,000	0.0%	$2.93	$2.93	—	COM	00773U108
GM	GENERAL MTRS CO	800	$28,000	0.0%	$35.00 *	$28.16	+4.4%	COM	37045V100